Serological markers are of significant importance in both the diagnosis and prognosis of breast cancer, with Ki67, CA 15-3, BAX, and Bcl-2 being notably characteristic in luminal subtype tumors [31,32]. This evidence concerns the gene BCL2 and breast cancer.